Actonel (Risedronate)

Overview
Actonel is a prescription drug approved by the Food and Drug Administration (FDA) to treat and prevent postmenopausal osteoporosis. Actonel is also indicated for men with osteoporosis and people with… read more

Alendronate or Alendronic acid

Overview
Alendronate is a prescription drug approved by the Food and Drug Administration (FDA) to treat and prevent postmenopausal osteoporosis. Alendronate is also indicated to increase bone mass in men with… read more

Atelvia (Risedronate)

Overview
Atelvia is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal osteoporosis. Atelvia is also referred to by its drug name, Risedronate, or Risendronic acid.… read more

Binosto (Alendronate Sodium)

Overview
Binosto is approved by the U.S. Food and Drug Administration (FDA) to treat osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. It is typically prescribed to people at high…

Boniva (Ibandronate)

Overview
Boniva is a prescription drug approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis in postmenopausal women. Boniva is also referred to by its drug name, Ibandronate, or… read more

Calcitonin

Overview
Calcitonin is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal osteoporosis in women who have been postmenopausal for at least five years. Calcitonin may be… read more

Clinical trials

Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for osteoporosis. Eligibility may be based on specifics of your condition and the severity of your… read more

Duavee (Conjugated estrogens/Bazedoxifene)

Overview
Duavee is a prescription medication approved by the Food and Drug Administration (FDA) to treat moderate to severe vasomotor symptoms of menopause, such as hot flashes and night sweats, and prevent… read more

Evenity (Romosozumab-aqqg)

Overview
Evenity is a prescription medication approved by the Food and Drug Administration (FDA) to treat osteoporosis in women after menopause who are at high risk of bone fracture, or who cannot use another… read more

Evista (Raloxifene)

Overview
Evista is a prescription medication approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis in postmenopausal women. Evista may be referred to by its drug name, Raloxifene.… read more

Forteo (Teriparatide [rDNA origin])

Overview
Forteo is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal women with osteoporosis who are at high risk for fracture. Forteo is also indicated to treat men with… read more

Fortical (Calcitonin-salmon)

The Fortical brand name has been discontinued in the U.S. Generic alternatives may be available.

Overview
Fortical is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal…

Fosamax (Alendronate)

Overview
Fosamax is a prescription drug approved by the Food and Drug Administration (FDA) to treat and prevent postmenopausal osteoporosis. Fosamax is also indicated to increase bone mass in men with osteoporosis and… read more

Hormone replacement therapy (HRT)

Overview
Estrogens and progesterone are hormones that have a protective effect on bone density. As women enter menopause, their bodies stop producing these hormones, raising the risk that they will develop osteoporosis.… read more

Ibandronate or Ibandronic acid

Overview
Ibandronate is a prescription drug approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis in postmenopausal women. Ibandronate is also called Ibandronic acid. Ibandronate is sold… read more

Miacalcin (Calcitonin-salmon)

The Miacalcin brand name has been discontinued in the U.S. Generic alternatives may be available.

Overview
Miacalcin is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal…

Prolia (Denosumab)

Overview
Prolia is a prescription medication approved by the Food and Drug Administration (FDA) to increase bone mass in women and men at high risk for fracture. Prolia is indicated for postmenopausal women with… read more

Raloxifene

Overview
Raloxifene is a prescription medication approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis in postmenopausal women. Raloxifene is also sold under the brand name Evista.… read more

Reclast (Zoledronic acid)

Overview
Reclast is a prescription drug approved by the Food and Drug Administration (FDA) to treat and prevent postmenopausal osteoporosis. Reclast is also indicated to increase bone mass in men with osteoporosis and… read more

Risendronate

Overview
Risedronate is a prescription drug approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis. Risedronate may be used to treat postmenopausal osteoporosis, men with osteoporosis, and… read more

Spinal surgery

Overview
In cases of osteoporosis where a vertebral compression fracture is causing severe pain or deformity that has not resolved with the use of a back brace, spinal surgery may become necessary.

What does it… read more

Stoboclo (Denosumab-Bmwo)

Overview
Stoboclo is approved by the U.S. Food and Drug Administration (FDA) for treatment for osteoporosis in postmenopausal women at high risk for fracture and to increase bone mass in men with osteoporosis at high risk…

Tymlos (Abaloparatide)

Overview
Tymlos is a prescription medication approved by the Food and Drug Administration (FDA) to treat postmenopausal women with osteoporosis who are at high risk for fracture. Tymlos may also be referred to by its… read more